相关实验视频

Updated: Jun 20, 2026

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions

Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions

Published on: October 21, 2017

通过GPR143促进L-DOPA的功能增殖,这是星体细胞的特定L-DOPA受体

Ye-Ji Kim^1,2, Gyeong Min Park³, Woo Kyung Cho³

¹Center for Global Biopharmaceutical Research, Korea Institute of Toxicology, Daejeon 34114, South Korea.

ACS chemical neuroscience

|November 7, 2024

概括

覆盖玻璃上的乐伏多巴 (L-DOPA) 涂层通过激活GPR143通路来促进天体细胞的增殖和功能. 这一发现为组织工程和再生医学提供了新的可能性.

科学领域:

神经科学是一个神经科学.
生物材料科学生物材料科学
细胞生物学细胞生物学

背景情况:

利沃多巴 (L-DOPA) 是生物相容的,用于帕金森病.
它对星球细胞 (主要的质细胞) 的影响尚不清楚.
作为一种生物材料涂层的L-DOPA的潜力值得研究.

研究的目的:

为了研究L-DOPA作为初级大鼠天体细胞的涂层材料的实用性.
确定L-DOPA对天体细胞增殖,功能和生存能力的影响.
阐明L-DOPA介导的星细胞反应中涉及的信号通路.

主要方法:

用L-DOPA涂层覆盖玻璃和聚钢.
使用X射线光电子谱学 (XPS) 和水接触角度 (WCA) 的表征.
评估星细胞的增殖,神经元的生长,Ca2+过渡物和生命力.
使用GPR143和RGS4抑制剂 (皮莫齐德,CCG2046).

主要成果:

覆盖玻璃上的L-DOPA涂层,而不是聚钢,促进了星球细胞的增殖.
用L-DOPA涂层的盖玻璃上的星体细胞通过PAR-1显示了功能性Ca2+过渡物.
L-DOPA涂层保持了星球细胞的活力,而高度的自由L-DOPA降低了它.
抑制剂建议L-DOPA通过GPR143激活促进星球细胞的增殖.

结论:

盖面玻璃上的L-DOPA涂层有效地增殖了功能性大鼠初级星球细胞.
这种增殖是由GPR143信号通路的激活介导的.
这一发现对组织工程和再生医学有重大影响.

关键词:

在Ca2+中存在过渡性物质.在 GPR1433 中使用.L-DOPA (莱沃多巴) 是一种星球细胞是星球细胞.它们的扩散和扩散.

更多相关视频

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Drugs Affecting Neurotransmitter Synthesis

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...